Unlock the full potential of Cryo-Fluorescence Tomography (CFT).
In this case study, researchers from Massachusetts General Hospital, Harvard Medical School showed how 2D in vivo fluorescence imaging (FLI) failed to accurately localize compounds in complex biological models, leading to misinterpretations. By integrating high resolution, 3D imaging through CFT, the study revealed critical anatomical and molecular insights that were missed using traditional optical imaging methods.
This case study highlights CFT’s superiority in sensitivity, resolution, and anatomical context compared to in vivo FLI. Learn how CFT corrected initial misinterpretations and provided reliable data in a fibrin-targeting drug study, empowering researchers to make better-informed decisions.
Download the full case study to discover how CFT can transform your preclinical research by filling out the form.
Additional Content
